NDC 83301-0004-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83301-0004
- Requested NDC
- 83301-0004-01
- Package NDCs from labels
- 83301-0004-1, 83301-0004-2, 83301-0004-3, 83301-0004-01
- Manufacturer
- Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd
- Effective date
- 2025-08-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd | Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd | 2025-08-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83301-0004-1 | Gabapentin | 100 in 1 BOTTLE, PLASTIC | CAPSULE | 100 | 10 | |
| 83301-0004-2 | Gabapentin | 500 in 1 BOTTLE, PLASTIC | CAPSULE | 500 | 10 | |
| 83301-0004-3 | Gabapentin | 1000 in 1 BOTTLE, PLASTIC | CAPSULE | 1000 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 83301-0004 | GABAPENTIN CAPSULE [MULLAN PHARMACEUTICAL INC.] | 9 | Current NDC, 3 package rows | 20250411_74474aa4-4859-42d2-92d8-f23f18b34e04.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 83301-0004-1 | EA - Each | 83301-0004 | 68147702-10bf-45ab-8778-32f3f1b00f3e | 1 | 2024-10-04 |
| 83301-0004-2 | EA - Each | 83301-0004 | 8f01f50a-eb39-445e-a88a-4f1145bc24d1 | 1 | 2025-07-08 |
| 83301-0004-3 | EA - Each | 83301-0004 | 36e8797a-1182-42cb-aee7-d954f67ee1ce | 1 | 2025-07-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Perfect Mineral Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | SKIN PERFECT MEDICAL | 4b47e7cb-17d6-6a7c-e063-6294a90abbea | 2026-02-20 | Warnings | 15FIX9V2JP |
| Calamine | FERRIC OXIDE RED | Perrigo Direct, Inc | 256bd1d4-fd50-408f-9aee-84f218bb4971 | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXIND HCL | Perrigo Direct, Inc | 54a20ec9-ab86-4410-af94-e04393e9d4b3 | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Meijer, Inc. | 6b369ef2-fd54-4931-a9eb-0fb42834c2ef | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Allay Skin Solutions Protect Nourish Mineral Sunscreen SPF 42 | TITANIUM DIOXIDE, ZINC OXIDE | ALLAY SKIN SOLUTIONS LLC | 425bf1d7-f2cf-4237-9047-dd53054acd1c | 2026-02-18 | Warnings | 15FIX9V2JP |
| Calamine | FERRIC OXIDE RED | Target Corporation | d4ee05c8-ae62-45df-8783-1ed57fa030ec | 2026-02-18 | Warnings, Adverse reactions | 1K09F3G675 |
| Hermes Plein Air-Baume de Teint Perfecteur Naturel-Enhancing Complexion Balm 85 TAMARIN | TITANIUM DIOXIDE | S.A. COMPTOIR NOUVEAU DE LA PARFUMERIE | dacff3dc-49d7-6416-e053-2a95a90a85c6 | 2026-02-18 | Warnings | 15FIX9V2JP |
| GABAPENTIN | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | 9814b76c-87c6-4746-b712-3269352a901b | 2026-02-16 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Calamine | FERRIC OXIDE RED | Topco Associates LLC | 2b32e720-ac71-4d60-bc06-e28a00f8a450 | 2026-02-13 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Topco Associates LLC | 15d1ae3f-509c-4e6b-8f0c-cf9265680358 | 2026-02-13 | Warnings, Adverse reactions | 1K09F3G675 |
| GABAPENTIN | GABAPENTIN | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | d8daa30f-1cb3-46aa-9b68-d9aa5b0a2105 | 2026-02-12 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | c979f80b-d4b1-40f7-b878-b216db5f325d | 2026-02-10 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | b88b0cbc-c883-4d17-8f46-0e5bddc57835 | 2026-02-10 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 3dbd447f-4791-4c62-86b4-6f7928862785 | 2026-02-10 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 081fd1de-acaa-4685-a053-4959d77b17e9 | 2026-02-10 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 0e1d17d5-d39c-4144-aac0-7c0d3bc9ec0d | 2026-02-09 | Warnings, Adverse reactions | 6CW7F3G59X |
| Alumier MD Clear Shield Broad Spectrum SPF 42 Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Alumier Labs | a9c970c8-b6e3-b0a1-e053-2a95a90a89c7 | 2026-02-09 | Warnings | 15FIX9V2JP |
| Droptics Performance Eye Drops | NAPHAZOLINE HYDROCHLORIDE, PROPYLENE GLYCOL | Droptics LLC | 20fd6822-a7fd-4593-92bb-0a07260893e2 | 2026-02-09 | Warnings | 6DC9Q167V3 |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 2343e3a1-82d0-4c70-a086-a01a0ce81ef3 | 2026-02-09 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 67330eef-c976-4862-b1ae-20f30f43df76 | 2026-02-09 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.